Asia Pacific Drug Modelling Software Market is expected to reach US$ 2,401.22 Mn in 2027
Published Date : 08/09/2020

Report : Asia Pacific Drug Modelling Software Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By roduct Type (Database, Software, and Others); Application (Drug Discovery and Development, Computational Physiological Medicine, Disease Modelling, Medical Imaging, Predictive Analysis of Drug Targets, Simulation Software, Cellular Simulation, and Others), and Country

Software Segment Held Largest Share of Drug Modelling Software Market in 2019

 

According to our new market research study on “Asia Pacific Drug Modelling Software Market to 2027 – Regional Analysis and Forecast – by Product Type, and Application” the market is expected to reach US$ 2,401.22 million by 2027 from US$ 1,252.66 million in 2019; it is estimated to grow at a CAGR of 8.8% from 2020 to 2027. The report provides trends prevailing in the Asia Pacific drug modelling software market and the factors driving the market growth along with those hindering it.

 

In 2019, the software segment accounted for the highest share of the market. Also, the same segment is estimated to grow at the highest CAGR in the forecast period. Growth of this segment is attributed to the growing demand for effective therapeutics and increase in drug discovery efforts of various biologics across a wide range of therapeutics. In addition, strategic activities by service providers such as collaborations, product advancement, and product launch in order to expediate drug discovery timeline are further accelerating the growth of the market.

 

The growth of the Asia Pacific drug modelling software market is mainly attributed to the rapid integration of AI for the drug discovery, increasing preference for personalized medicine, high R&D spending for novel therapeutic applications and presence of major market players. However, the less adoption in emerging countries is the major factor hindering the market growth in Asia Pacific.

 

Genedata AG; Biognos AB; Dassault Systèmes; Acellera; and Crown Bioscience Inc (JSR life science) are among the leading companies operating in the Asia Pacific drug modelling software market.


Asia Pacific Drug Modelling Software Market, By Country, 2019 (%)

Asia Pacific Drug Modelling Software Market, By Country, 2019 (%)

 

The Report Segments Asia Pacific Drug Modelling Software Market as Follows:

Asia Pacific Drug Modelling Software Market – By Product Type

  • Database
  • Software
  • Others

 

Asia Pacific Drug Modelling Software Market – By Application

  • Drug Discovery and Development
  • Computational Physiological Medicine
  • Disease Modelling
  • Medical Imaging
  • Predictive Analysis of Drug Targets
  • Simulation Software
  • Cellular Simulation
  • Others  

 

Asia Pacific Drug Modelling Software Market – By Country

  • Asia Pacific
  • India
  • China
  • Japan
  • South Korea
  • Australia
DOWNLOAD PDF BROCHURE